About Aetion
Aetion is a Healthcare company based in New York (United States) founded in 2012, and was acquired by Datavant in May 2025. It provides payerprovider, biopharma and medical device customers with a platform to allow them to gain insights into the clinical and financial status of a population. Aetion has raised $203.6 million across 5 funding rounds from investors including Amgen, UCB and Datavant. Aetion has completed 1 acquisition, including Replica Analytics. Aetion offers products and services including Aetion Evidence Platform, Aetion Discover, Aetion Substantiate, Aetion Generate, and Regulatory and Scientific Services. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Volume-to-Value Transition. Its legal entity is AETION, INC. Its competitors include Aledade, Lumeris and Arcadia; 3 of its 3 listed competitors have raised funding.
Company details
Aetion provides payerprovider, biopharma and medical device customers with a platform which combines science with computing technology to allow them to gain insights into the clinical and financial status of a population, measure and compare the effectiveness and value of treatments and provider practices and realize value-based contracting. The Aetion Evidence Platform works with all healthcare data including claims, electronic health records, registries, and clinical trials. Aetions Evidence Generation application helps payers rapidly determine what treatments and medical interventions work in the real world. The Aetion Evidence Platform provides analytic methods and real-time evidence that allow payers to generate risk-adjusted insights and to fully quantify and communicate the value in their populations. The platform also enables payers and providers to collaborate in real-time with biopharmaceutical and medical device companies to develop therapeutic insights and make smart choices in patient care.
- Headquarters New York, United States
- Stage Acquired
- SectorsHealthcare
- Website aetion.com
- Social LinkedIn X
- Acquired by Datavant (May 2025)
- Legal Name Aetion, Inc.
Products & Services of Aetion
Aetion offers a comprehensive portfolio of products and services, including Aetion Evidence Platform, Aetion Discover, Aetion Substantiate, Aetion Generate, and Regulatory and Scientific Services.
Platform for managing and analyzing longitudinal health data
App for generating quick insights from real-world data
App for examining data to support critical healthcare decisions
App using AI for synthetic health data generation
Services to accelerate real-world evidence strategies
Funding Insights of Aetion
Aetion has successfully raised a total of $203.6M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $110 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $203.6M
- Total Rounds 5
- Last Round Series C — $110M
- First Round $11.2M
(Mar 2017)
- Investors Count 17
All 5 funding rounds of Aetion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $110M | Series C | – | Warburg Pincus | |
| Aug 2020 | $19M | Series B | – | Johnson & Johnson Innovation – JJDC, EDBI | |
| Feb 2019 | $27M | Series B | – | McKesson Ventures, UCB | |
| Apr 2018 | $36.4M | Series B | – | New Enterprise Associates, Amgen | |
| Mar 2017 | $11.2M | Series A | – | Flare Capital Partners |
18 investors in total: 18 institutional.
Investors in Aetion
Aetion has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, UCB and Datavant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-stage private equity investments are pursued across diverse sectors. | 1966 | warburgpincus.com | New York, United States | |
Multi-stage investment firm invests in healthcare and life sciences companies | foresitecapital.com | New York, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Early-stage tech startups are funded by this venture capital firm. | flarecapital.com | Boston, United States | ||
Multistage investments are directed toward technology, healthcare, and climate sectors. | b.capital | Manhattan Beach, United States | ||
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Government-backed investments are directed toward healthcare, fintech, and various sectors. | edbi.com | Singapore, Singapore | ||
Diversified investment management firm | 2000 | greenspringassociates.com | Owings Mills, United States | |
Venture capital investment firm | 2012 | lakestar.com | Zurich, Switzerland | |
Investments are directed by McKesson Ventures toward early-stage healthcare startups. | ventures.mckesson.com | San Francisco, United States |
Investor details for Aetion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aetion
119 people are tracked at Aetion (55 in leadership, 12 in board & advisors, 52 in team).
| Name | Role | Group |
|---|---|---|
David Vavrasek | Chief Business Officer | Leadership |
Nicolle Gatto | Chief Science Officer | Leadership |
Drew Roberts | Senior Director, Science | Leadership |
Marie Madec | Head Of People (eu) | Leadership |
Melanie Wang | Senior Director of Research Operations | Leadership |
Michelle Skornicki | Senior Director, Science | Leadership |
Jennifer Demeter Borgogno | Director, RWD Solutions | Leadership |
James Miguel Pierce | Head, Science Operations | Leadership |
Ann Madsen | VP, Science | Leadership |
Coralie Lecomte | Sr. Director Science (eu) | Leadership |
Simon Williams | Director, Commercial Product Lead, Medical Device & Diagnostics | Leadership |
Michelle Saffranella | Director | Leadership |
Gulce Askin | Director | Leadership |
Reno Leeming | Associate Director, Science | Leadership |
Patrick Arena | Director, Science | Leadership |
Natalie Levy | Director, Scientific Strategy | Leadership |
Emily Rubinstein | Vice President Of Global Scientific Data Insights | Leadership |
Lucy Mosquera | Sr Director Generate Ops & Data Science | Leadership |
Anabel Ferreras, PMP | Senior Engagement Director | Leadership |
Olivier Moussalli | Client Partner | Leadership |
99 more people are available in the full profile.
Complete people profiles for Aetion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aetion
Aetion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Replica Analytics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Synthetic data is generated from real datasets with privacy assurance. | replica-analytics.com | Ottawa, Canada | 2019 | Jan 2022 | •••• |
Complete acquisition details for Aetion
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aetion
5 dated milestones of Aetion across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Aetion is founded.
- Funding First funding round of $11.2M.
- Funding Latest funding round, Series C, of $110.0M.
- Acquisition Acquires Replica Analytics.
- Exit Acquired by Datavant.
Competitors of Aetion
Aetion has 3 listed competitors in our database, 3 of them funded. They include Aledade, Lumeris and Arcadia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aledade.com | 2014 | Bethesda, United States | $780.49M | 1,346 | Primary care physician platform for patient care delivery is provided. | |
| lumeris.com | 2001 | Maryland Heights, United States | $477.3M | 1,375 | Lumeris offers population management and accountable care solutions | |
| arcadia.io | 2002 | Boston, United States | $72.5M | 409 | AI-based healthcare data analytics platform is provided for organizations. |
Detailed competitors of Aetion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aetion
The website of Aetion (aetion.com) receives about 7.4K visits a month.
- Monthly visits7.4K
▼ 19.6% vs previous month
Websites whose visitors overlap most with Aetion. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| truveta.com | 100% | 27.2K | #947,909 | View details | |
| hioscar.com | 90% | 2.8M | #16,829 | View details | |
parenting.org | parenting.org | 69% | #1,383,731 | – |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Aetion (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aetion
Complete news archive for Aetion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aetion
Aetion was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Aetion is headquartered in New York, United States. It is registered at New York, New York, United States.
Aetion is a funded company, having raised a total of $203.6M across 5 funding rounds to date. The company's 1st funding round was a Series A of $11.2M, raised on Mar 2017.
Aetion provides payerprovider, biopharma and medical device customers with a platform which combines science with computing technology to allow them to gain insights into the clinical and financial status of a population, measure and compare the effectiveness and value of treatments and provider practices and realize value-based contracting. The Aetion Evidence Platform works with all healthcare data including claims, electronic health records, registries, and clinical trials. Aetions Evidence Generation application helps payers rapidly determine what treatments and medical interventions work in the real world. The Aetion Evidence Platform provides analytic methods and real-time evidence that allow payers to generate risk-adjusted insights and to fully quantify and communicate the value in their populations. The platform also enables payers and providers to collaborate in real-time with biopharmaceutical and medical device companies to develop therapeutic insights and make smart choices in patient care.
Aetion offers Aetion Evidence Platform, Aetion Discover, Aetion Substantiate, Aetion Generate, and Regulatory and Scientific Services.
Aetion has made 1 acquisition, including Replica Analytics.
Aetion has 18 investors. Key investors include Amgen, UCB, Datavant, Warburg Pincus, and Lakestar.
Aetion operates through Aetion, Inc..
Yes. Aetion was acquired by Datavant in May 2025.